Clozapine replacement by quetiapine for dopamimetic psychosis in Parkinson's disease

被引:0
|
作者
Fernandez, H
Friedman, JH
Lannon, MC
机构
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:491 / 491
页数:1
相关论文
共 50 条
  • [1] Clozapine serum concentrations in dopamimetic psychosis in Parkinson's disease and related disorders
    Lutz, Ulrich C.
    Sirfy, Ahmad
    Wiatr, Gerlinde
    Altpass, Danuta
    Farger, Gisbert
    Gasser, Thomas
    Karle, Kathrin N.
    Batra, Anil
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (12) : 1471 - 1476
  • [2] Clozapine replacement by quetiapine for the treatment of drug-induced psychosis in Parkinson's disease
    Fernandez, HH
    Lannon, MC
    Friedman, JH
    Abbott, BP
    [J]. MOVEMENT DISORDERS, 2000, 15 (03) : 579 - 581
  • [3] Clozapine serum concentrations in dopamimetic psychosis in Parkinson’s disease and related disorders
    Ulrich C. Lutz
    Ahmad Sirfy
    Gerlinde Wiatr
    Danuta Altpaß
    Gisbert Farger
    Thomas Gasser
    Kathrin N. Karle
    Anil Batra
    [J]. European Journal of Clinical Pharmacology, 2014, 70 : 1471 - 1476
  • [4] Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease
    Dewey, RB
    O'Suilleabhain, PE
    [J]. NEUROLOGY, 2000, 55 (11) : 1753 - 1754
  • [5] Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease
    Brandstädter, D
    Oertel, WH
    [J]. NEUROLOGY, 2002, 58 (01) : 160 - 161
  • [6] Treatment of drug-induced psychosis with quetiapine and clozapine in Parkinson's disease - Reply
    Dewey, RB
    O'Suilleabhain, PE
    [J]. NEUROLOGY, 2002, 58 (01) : 161 - 161
  • [7] Rater-blinded, prospective comparison: Quetiapine versus clozapine for Parkinson's disease psychosis
    Merims, Doron
    Balas, Meirav
    Peretz, Chava
    Shabtai, Herzel
    Giladi, Nir
    [J]. CLINICAL NEUROPHARMACOLOGY, 2006, 29 (06) : 331 - 337
  • [8] THE COST-EFFECTIVENESS OF CLOZAPINE VS. QUETIAPINE IN THE TREATMENT OF PARKINSON'S DISEASE PSYCHOSIS
    Chekani, F.
    Sansgiry, S. S.
    [J]. VALUE IN HEALTH, 2017, 20 (05) : A193 - A193
  • [9] Behavioral effects of clozapine, pimavanserin, and quetiapine in rodent models of Parkinson's disease and Parkinson's disease psychosis: evaluation of therapeutic ratios
    Hubbard, David
    Hacksell, Uli
    McFarland, Krista
    [J]. BEHAVIOURAL PHARMACOLOGY, 2013, 24 (07): : 628 - 632
  • [10] Clozapine as a treatment of psychosis in Parkinson's disease
    Ozsancak, C
    Auzou, P
    Ronziere, T
    Hannequin, D
    Augustin, P
    [J]. PRESSE MEDICALE, 1997, 26 (33): : 1599 - 1602